BioMarin drug fails to show inattention, mood benefit in study
 

BioMarin drug fails to show inattention, mood benefit in study
(Reuters) - BioMarin Pharmaceutical Inc's drug met a study's main goal of reducing a toxic buildup of an ami** acid in the blood of patients with a genetic disorder, but did **t show e**ugh benefit in related inattention and mood complications.


http://rc.feedsportal.com/r/24739537...14/rc/1/rc.img

http://rc.feedsportal.com/r/24739537...14/rc/2/rc.img

http://rc.feedsportal.com/r/24739537...14/rc/3/rc.img

http://da.feedsportal.com/r/24739537...7/sc/14/a2.img
http://adchoice.feedsportal.com/r/24.../sc/14/ach.imghttp://pi.feedsportal.com/r/24739537.../sc/14/a2t.imghttp://pi2.feedsportal.com/r/2473953...sc/14/a2t2.imghttp://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1 http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...E4:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...E4:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/k-0AZfmdUR4